Cargando…
The Metabotropic Purinergic P2Y Receptor Family as Novel Drug Target in Epilepsy
Epilepsy encompasses a heterogeneous group of neurological syndromes which are characterized by recurrent seizures affecting over 60 million people worldwide. Current anti-epileptic drugs (AEDs) are mainly designed to target ion channels and/or GABA or glutamate receptors. Despite recent advances in...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5851315/ https://www.ncbi.nlm.nih.gov/pubmed/29563872 http://dx.doi.org/10.3389/fphar.2018.00193 |